Intravenous immune globulin in chronic lymphocytic leukaemia.

Intravenous immune globulin in chronic lymphocytic leukaemia.

The most common complication of chronic lymphocytic leukaemia (CLL) is infection, which occurs mainly in advanced stages of disease or in those patients with hypogammaglobulinaemia. Intravenous immune globulin (IVIG) has been shown to be a useful prophylactic therapy against infections in such patie...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Gamm, H, Huber, C, Chapel, H, Lee, M, Ries, F, Dicato, M
Formaat:	Conference item
Gepubliceerd in:	1994

Gelijkaardige items

Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
door: Dicato, M, et al.
Gepubliceerd in: (1991)

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes.
door: Chapel, H, et al.
Gepubliceerd in: (1994)

Treatment of neonatal sepsis with intravenous immune globulin.
door: Brocklehurst, P, et al.
Gepubliceerd in: (2011)

Predictors of infection in chronic lymphocytic leukaemia (CLL).
door: Griffiths, H, et al.
Gepubliceerd in: (1992)

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.
door: Gamm, H, et al.
Gepubliceerd in: (1988)

Immunoglobulin replacement in chronic lymphocytic leukaemia.
door: Bunch, C
Gepubliceerd in: (1988)

MicroRNA expression in chronic lymphocytic leukaemia.
door: Lawrie, C, et al.
Gepubliceerd in: (2009)

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.
door: Oscier, D, et al.
Gepubliceerd in: (2012)

The study of DNA methylation anomalies in chronic lymphocytic leukaemia
door: Roy, NBA
Gepubliceerd in: (2011)

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
door: Parker, H, et al.
Gepubliceerd in: (2016)

Collaborative meta-analysis of randomised trials in chronic lymphocytic leukaemia (CLL)
door: Binet, J, et al.
Gepubliceerd in: (1998)

Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia.
door: Bruce, DR, et al.
Gepubliceerd in: (2014)

Diminished thyroxine-binding globulin in pubertal diabetic children.
door: Connors, M, et al.
Gepubliceerd in: (1996)

Intravenous immunoglobulin therapy.
door: Chapel, H
Gepubliceerd in: (1996)

Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
door: Lander, Eric Steven
Gepubliceerd in: (2017)

Characterisation of the mutational landscape of chronic lymphocytic leukaemia using genome-wide approaches
door: Alsolami, R
Gepubliceerd in: (2017)

Prognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysis (Protocol)
door: Skoetz, N, et al.
Gepubliceerd in: (2016)

Chronic neutrophilic leukaemia.
door: Gan, G.G., et al.
Gepubliceerd in: (2007)

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
door: Hale, G, et al.
Gepubliceerd in: (2004)

Preliminary results of the UK Medical Research Council trial in chronic lymphocytic leukaemia - CLL3
door: Catovsky, D, et al.
Gepubliceerd in: (1998)

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype
door: Burns, A, et al.
Gepubliceerd in: (2012)

Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype
door: Burns, A, et al.
Gepubliceerd in: (2012)

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial.
door: Dearden, C, et al.
Gepubliceerd in: (2011)

Home intravenous immunoglobulin therapy.
door: Chapel, H, et al.
Gepubliceerd in: (1988)

Hepatitis C and intravenous immunoglobulin - Concluding remarks
door: Chapel, H
Gepubliceerd in: (1996)

Patients’ preferences for genomic diagnostic testing in chronic lymphocytic leukaemia: a discrete choice experiment
door: Buchanan, J, et al.
Gepubliceerd in: (2016)

Incurable, invisible and inconclusive: watchful waiting for chronic lymphocytic leukaemia and implications for doctor-patient communication.
door: Evans, J, et al.
Gepubliceerd in: (2012)

Prognostic models for newly‐diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta‐analysis
door: Kreuzberger, N, et al.
Gepubliceerd in: (2020)

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
door: Steurer, M, et al.
Gepubliceerd in: (2006)

The significance of deletion architecture, ATM mutational status and genomic complexity in 11q deleted Chronic Lymphocytic Leukaemia
door: Rose-Zerilli, M, et al.
Gepubliceerd in: (2012)

Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.
door: Bass, E, et al.
Gepubliceerd in: (1993)

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
door: Kasar, S., et al.
Gepubliceerd in: (2017)

Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
door: Chowdhury, O, et al.
Gepubliceerd in: (2011)

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features
door: Clifford, R, et al.
Gepubliceerd in: (2012)

Intravenous immunoglobulin and hepatitis C virus: the British episode.
door: Healey, C, et al.
Gepubliceerd in: (1996)

Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing.
door: Bosanquet, A, et al.
Gepubliceerd in: (2009)

Conservation within cytotoxic T lymphocyte epitopes in hepatitis C virus in chronic infection.
door: Christie, J, et al.
Gepubliceerd in: (1997)

Effective interactions and colloidal stability of bovine γ-globulin in solution
door: Da Vela, S, et al.
Gepubliceerd in: (2017)

Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
door: Rees-Unwin, K, et al.
Gepubliceerd in: (2010)

Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis
door: Buchanan, J, et al.
Gepubliceerd in: (2017)